Dr. Carlos Eduardo dos Santos Ferreira
Hospital Israelita Albert Einstein, São Paulo
Evaluating Graves’ patients on radioiodine therapy with IMMULITE TSI Assay
8 Oct 2020
In this video, Dr. Carlos Eduardo dos Santos Ferreira, Medical Manager of Clinical Pathology at Hospital Israelita Albert Einstein, São Paulo, shares the results of a study validating the IMMULITE 2000 TSI Assay from Siemens Healthineers and evaluating the results of this assay versus conventional TRAb tests.
LIKE
6
Featured technology
Related Scientists
-
-
-
Clinical Laboratory Diagnostics EndocrinologyDra. Cleide de Oliveira Weingrill Sabino DASA, São Paulo, Brazil -
-
-
Clinical Laboratory DiagnosticsLori B. Daniels, MD, FACC UC San Diego Health & UC San Diego School of Medicine -
-
-
-
-
Clinical Laboratory DiagnosticsDr. Vu Duc Binh National Institute of Hematology and Blood Transfusion (NIHBT), Hanoi, Vietnam -
-
-
Clinical Laboratory DiagnosticsPatti DeJuilio Respiratory Care Services and Sleep Center, Northwestern Medicine Central DuPage Hospital -
-
EndocrinologyDr. SM Hossein Sadrzadeh, PhD., DABCC, FACB Chief of Clinical Biochemistry Section, Calgary Laboratory Services, University of Calgary
-
-
Clinical Laboratory DiagnosticsJim Freeman Vice President, Research and Development, Global Immunoassay Development, Siemens Healthineers
Related Content
Endocrinology
Clinical Laboratory Diagnostics